Back

Post-activity quiz and discussion

31 August 2019 (16:35 - 16:40)
Organised by:
Congress Presentation Part of: Targeting of PCSK9 with siRNA for LDL-C reduction in a high-risk population Coronary Artery Disease (Chronic) / Chronic Coronary Syndromes (CCS) ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Pamela MORRIS

Medical University of South Carolina, Charleston (United States of America)

4 More presentations in this session

Presentation thumbnail
Clinical implications for patients at persistent ASCVD risk
Doctor J. Saseen (Aurora, US)
Slides Video
Presentation thumbnail
Clinical trial updates
Doctor C. Ballantyne (Houston, US)
Slides Video
Presentation thumbnail
The future of lipid management: new therapies for LDL-C lowering
Doctor H. Bays (Louisville, US)
Slides Video
Presentation thumbnail
Questions and answers / Panel discussion
Slides Video

Access the full session

Session thumbnail
Targeting of PCSK9 with siRNA for LDL-C reduction in a high-risk population

The Event

Event poster

ESC Congress 2019

31 August 2019 16:35 CET
You may be interested in
thumbnail
Congress Presentation
State-of-the-art lecture beyond antithrombotic therapies in PCI: role of lipids, inflammation, and therapies on the horizon
28 August 2023
thumbnail
Congress Presentation
Forging the path: strategic combinations to achieve lipid targets
29 August 2025
thumbnail
Congress Presentation
Key takeaways & practical guidance
29 August 2025
thumbnail
Congress Presentation
Breaking through: CETP inhibitors and the future of lipid therapy
29 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources